Journal/Conference

British Journal of Pharmaceutical Research

About

British Journal of Pharmaceutical Research (BJPR) (ISSN: 2231-2919) is dedicated to publish high quality papers (Click here for Types of paper) in all areas of pharmaceutical Science including pharmaceutical drugs, community pharmacy, hospital pharmacy, clinical pharmacy, compounding pharmacy, consultant pharmacy, internet pharmacy, veterinary pharmacy, nuclear pharmacy, military pharmacy, pharmacy informatics, pharmaceutics, medicinal chemistry, pharmacognosy, pharmacotherapy, pharmacodynamics, pharmacokinetics, clinical pharmacology, neuropharmacology, psychopharmacology, pharmacogenetics, pharmacogenomics, pharmacoepidemiology, toxicology, theoretical pharmacology, posology, pharmacognosy, behavioral pharmacology, environmental pharmacology, medicine development and safety testing, drug legislation and safety. The journal also encourages the submission of useful reports of negative results. This is a quality controlled, OPEN peer reviewed, open access INTERNATIONAL journal.

Published by
Review policy on Publons
  • Does not allow reviews to be publicly displayed
  • Only allows reviewers to display the journal they reviewed for
Reviews

348

Interested in reviewing for this journal?

Your interest in reviewing is shared with journals or conferences when they are partnered with us. Learn more.

Top handling editors on Publons (Manuscripts handled)
Editorial board members on Publons

Publons users have indicated that they sit on British Journal of Pharmaceutical Research's editorial board but we are unable to verify these claims. If you are an administrator for British Journal of Pharmaceutical Research, please get in touch to find out how you can verify the contributions of your editorial board members and more.

Top reviewers on Publons (Manuscripts reviewed in last 12 months)
Endorsed by
Journal/Conference Endorsement

Reviews

Review contents for British Journal of Pharmaceutical Research are not publicly displayed on Publons, in accordance with their editorial policy.